|
US4496542A
(en)
|
1981-03-30 |
1985-01-29 |
Usv Pharmaceutical Corporation |
N-substituted-amido-amino acids
|
|
FR2504010B1
(fr)
|
1981-04-15 |
1985-10-25 |
Sanofi Sa |
Medicaments anticancereux contenant la chaine a de la ricine associee a un anticorps antimelanome et procede pour leur preparation
|
|
US4671958A
(en)
|
1982-03-09 |
1987-06-09 |
Cytogen Corporation |
Antibody conjugates for the delivery of compounds to target sites
|
|
DE3377484D1
(en)
|
1982-04-19 |
1988-09-01 |
Nissan Motor |
Method for controlling reduction ratio of continuously variable transmission with acceleration compensation
|
|
US4542225A
(en)
|
1984-08-29 |
1985-09-17 |
Dana-Farber Cancer Institute, Inc. |
Acid-cleavable compound
|
|
US4659839A
(en)
|
1984-10-10 |
1987-04-21 |
Mallinckrodt, Inc. |
Coupling agents for radiolabeled antibody fragments
|
|
ATE66469T1
(de)
|
1985-01-14 |
1991-09-15 |
Neorx Corp |
Metall-radionuklid markiertes protein fuer diagnose und therapie.
|
|
US4680338A
(en)
|
1985-10-17 |
1987-07-14 |
Immunomedics, Inc. |
Bifunctional linker
|
|
US4699784A
(en)
|
1986-02-25 |
1987-10-13 |
Center For Molecular Medicine & Immunology |
Tumoricidal methotrexate-antibody conjugate
|
|
CH677886A5
(cg-RX-API-DMAC10.html)
|
1989-06-26 |
1991-07-15 |
Hans Georg Prof Dr Weder |
|
|
US5397772A
(en)
|
1989-06-29 |
1995-03-14 |
The President And Fellows Of Harvard College |
Vasodilatory peptides from the salivary gland of the sand fly Lutzomyia longipalpis
|
|
US5480864A
(en)
|
1993-08-06 |
1996-01-02 |
Shiseido Co., Ltd. |
Modified maxadilan protein, its preparation and use, and DNA encoding the protein
|
|
KR950007873A
(ko)
|
1993-09-20 |
1995-04-15 |
후꾸하라 요시하루 |
생리 활성 물질 지속 방출형의 의약 제제
|
|
ES2094688B1
(es)
|
1994-08-08 |
1997-08-01 |
Cusi Lab |
Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
|
|
FR2730932B1
(fr)
|
1995-02-27 |
1997-04-04 |
Oreal |
Nanoemulsion transparente a base de lipides amphiphiles non-ioniques fluides et utilisation en cosmetique ou en dermopharmacie
|
|
US6462016B1
(en)
|
1995-10-06 |
2002-10-08 |
Shiseido Company, Ltd. |
Method for screening agonist or antagonist of the maxadilan receptor participating in vasodilating action, and compound found by the method
|
|
FR2742676B1
(fr)
|
1995-12-21 |
1998-02-06 |
Oreal |
Nanoemulsion transparente a base de tensioactifs silicones et utilisation en cosmetique ou en dermopharmacie
|
|
US6017533A
(en)
|
1996-04-25 |
2000-01-25 |
Shiseido Company, Ltd. |
Peptides having specific affinity to pituitary adenylate cyclase activating polypeptide type 1 receptors
|
|
FR2755854B1
(fr)
|
1996-11-15 |
1998-12-24 |
Oreal |
Nanoemulsion a base de lipides amphiphiles non-ioniques et cationiques et utilisations
|
|
FR2760970B1
(fr)
|
1997-03-18 |
2000-03-10 |
Oreal |
Nanoemulsions a base de lipides amphiphiles non-ioniques et de silicones aminees et utilisations
|
|
DE69941708D1
(de)
|
1998-07-20 |
2010-01-07 |
Ipsen Pharma |
Pacap-peptidanaloga
|
|
FR2787026B1
(fr)
|
1998-12-14 |
2001-01-12 |
Oreal |
Nanoemulsion a base d'esters mixtes d'acide gras ou d'alcool gras, d'acide carboxylique et de glyceryle, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2787027B1
(fr)
|
1998-12-14 |
2001-01-12 |
Oreal |
Nanoemulsion a base d'esters gras de sucre ou d'ethers gras de sucre et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2787325B1
(fr)
|
1998-12-17 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras de sorbitan oxyethylenes ou non oxyethylenes, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2787326B1
(fr)
|
1998-12-17 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras de glycerol, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2787728B1
(fr)
|
1998-12-23 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras d'acide phosphorique, et ses utilisations dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
|
FR2787703B1
(fr)
|
1998-12-29 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'ethers gras ethoxyles ou d'esters gras ethoxyles, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2788007B1
(fr)
|
1999-01-05 |
2001-02-09 |
Oreal |
Nanoemulsion a base de copolymeres blocs d'oxyde d'ethylene et d'oxyde de propylene, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2788449B1
(fr)
|
1999-01-14 |
2001-02-16 |
Oreal |
Nanoemulsion a base de citrates d'alkylether, et ses utilisations dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
|
FR2789076B1
(fr)
|
1999-02-02 |
2001-03-02 |
Synthelabo |
Derives de alpha-azacyclomethyl quinoleine, leur preparation et leur application en therapeutique
|
|
NZ534409A
(en)
|
1999-04-05 |
2006-03-31 |
Emisphere Tech Inc |
Disodium salts, monohydrates, and ethanol solvates for delivering active agents
|
|
WO2001085100A2
(en)
*
|
2000-05-11 |
2001-11-15 |
The General Hospital Corporation |
Vasodilator-thrombolytic fusion proteins and conjugates
|
|
FR2811564B1
(fr)
|
2000-07-13 |
2002-12-27 |
Oreal |
Nanoemulsion contenant des polymeres non ioniques, et ses utilisations notamment dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
|
US20020182729A1
(en)
|
2001-01-11 |
2002-12-05 |
Dicicco-Bloom Emanuel |
Pituitary adenylate cyclase-activating polypeptide (PACAP) is an anti-mitogenic signal for selected neuronal precursors in vivo
|
|
FR2819427B1
(fr)
|
2001-01-18 |
2003-04-11 |
Oreal |
Nanoemulsion translucide, son procede de fabrication et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
EP2545937A1
(en)
|
2001-06-05 |
2013-01-16 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
|
WO2003092716A2
(en)
|
2002-05-03 |
2003-11-13 |
Neuronova Ab |
Therapeutic use of pacap, maxadilan, pacap receptor agonist and/or adcyap1r1 in the treatment of cns disorders
|
|
US7476393B2
(en)
|
2002-11-29 |
2009-01-13 |
L'oreal |
Process for the preparation of a cationic nanoemulsion, and cosmetic composition
|
|
US7928186B2
(en)
|
2006-08-02 |
2011-04-19 |
Phoenix Pharmaceuticals, Inc. |
Cell permeable bioactive peptide conjugates
|
|
CN101125882B
(zh)
*
|
2007-07-20 |
2010-10-13 |
暨南大学 |
重组pac1受体激动剂rmmax及其表达方法与应用
|
|
CN102215859B
(zh)
|
2008-09-25 |
2016-04-20 |
图兰恩教育基金管理人 |
垂体腺苷酸环化酶激活多肽(pacap)以及pacap类似物作为与抗癌剂一起的辅助治疗的用途
|
|
JP5908406B2
(ja)
*
|
2009-11-02 |
2016-04-26 |
ジ アドミニストレーターズ オブ ザ トゥレーン エデュケーショナル ファンド |
下垂体アデニル酸シクラーゼ活性化ポリペプチド(pacap)の類似体およびその使用方法
|
|
CA2788835A1
(en)
|
2010-02-05 |
2011-08-11 |
The Administrators Of The Tulane Educational Fund |
The use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs as adjunctive treatments with inhibitors of calcineurin or inhibitors of the mammalian target of rapamycin (mtor) complexes
|
|
WO2012106407A2
(en)
|
2011-02-01 |
2012-08-09 |
The University Of Vermont And State Agricultural College |
Diagnostic and therapeutic methods and products related to anxiety disorders
|
|
AU2014276379A1
(en)
|
2013-06-07 |
2016-01-07 |
The Administrators Of The Tulane Educational Fund |
Analogs of pituitary adenylate cyclase-activating polypeptide (PACAP) and methods for their use
|
|
CA3049212A1
(en)
|
2017-01-05 |
2018-07-12 |
The Regents Of The University Of California |
Pac1 receptor agonists (maxcaps) and uses thereof
|